The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The First 1000 Dendritic Cell Vaccinees
Abstract
Dendritic cells (DCs) are potent antigen-presenting cells that have the ability to stimulate primary T cell antitumor immune responses in animals and humans. Since the first published clinical trial of dendritic cell vaccination in 1995, 98 studies describing more than 1000 vaccinees have been published in peer-reviewed medical journals or presented at the annual meetings of the American Society for Clinical Oncology, the American Association of Cancer Research, or the American Society of Hematology. Trials have been performed in 15 countries. Trials included patients with more than two dozen tumor types; most trials studied patients with malignant melanoma, prostate cancer, colorectal carcinoma, or multiple myeloma, using autologous DCs pulsed with synthetic antigens or idiotype antibodies. The DC vaccines were also prepared by pulsing DCs with tumor lysates or RNA, by transfection with tumor DNA, or by creating tumor cell/DC fusions. Various approaches to vaccine cell numbers, length of vaccine program, site of vaccination, frozen preservation of vaccine, and use of a maturations step for DCs were used. Adverse effects associated with DC vaccination were uncommon; most were mild and self-limited and none were serious. Clinical responses were observed in approximately half the trials. The DC vaccination may provide a safe approach to cancer immunotherapy that can overcome the limited reach and immunogenicity of peptide vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kugler, A., Stuhler, G., Walden, P., Zöller, G., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Müller, C. A., Becker, V., et al. (2000) · Nature Medicine · doi:10.1038/73193 · Cited by 639
RetractedVaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
(2011) · Hepatogastroenterology · doi:10.5754/hge11753 · Cited by 2,435
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804 · cited 2×
“Specifically, 3 of the 17 studies examined mature DC vaccines,([47,54,61]) 2 specified the use of frozen cells,([54,61]) 2 specified the use of freshly prepared vaccines,([42,56]) 7 administered subcutaneous vaccinations,([4,7,43,54,61,65,103]) 8 administered iv vaccinations,([4,39,42,46,47,51,71,82]) 2 administered i…”
BackgroundThurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1669 · Cited by 1,226
Banchereau, J., Palucka, A. K., Dhodapkar, M. V., Burkeholder, S. B., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., et al. (2001) · PubMed · Cited by 806
Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells
Small, E. J., Fratesi, P., Reese, D. M., Strang, G., Laus, R., Peshwa, M. V., & Valone, F. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3894 · Cited by 625
Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214364 · Cited by 562
Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., & Brugger, W. (2000) · Blood · doi:10.1182/blood.v96.9.3102 · Cited by 552
Timmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., Hao, Z. M., Taidi, B., Rajapaksa, R., Caspar, C. B., Okada, C. Y., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1517 · Cited by 545
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., & Engleman, E. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141226398 · Cited by 541
Yu, J. S., Wheeler, C. J., Zeltzer, P. M., Ying, H., Nacis-Finger, D., Lee, P.-K., Yong, W. H., Incardona, F., Thompson, R. C., Riedinger, M. S., et al. (2001) · PubMed · Cited by 510
Schuler-Thurner, B., Schultz, E. S., Berger, T. G., Weinlich, G., Ebner, S., Woerl, P., Bender, A., Feuerstein, B., Fritsch, P. O., Romani, N., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012100 · Cited by 475
Migration of human dendritic cells after injection in patients with metastatic malignancies.
Morse, M. A., Coleman, R., Akabani, G., Niehaus, N., Coleman, D., & Lyerly, H. K. (1999) · PubMed · Cited by 381
Jonuleit, H., Giesecke-Tuettenberg, A., T�ting, T., Thurner-Schuler, B., Stuge, T. B., Paragnik, L., Kandemir, A., Lee, P. P., Schuler, G., Knop, J., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1323 · Cited by 375
Mackensen, A., Herbst, B., Chen, J.-L., K�hler, G., Noppen, C., Herr, W., Spagnoli, G. C., Cerundolo, V., & Lindemann, A. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t · Cited by 345
Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients
Fong, L., Brockstedt, D., Benike, C., Wu, L., & Engleman, E. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4254 · Cited by 343
Mukherji, B., Chakraborty, N. G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J. R., Kurtzman, S. K., Ergin, M. T., Ozols, J., & Meehan, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.8078 · Cited by 326
Geiger, J. D., Hutchinson, R. J., Hohenkirk, L., McKenna, E. A., Yanik, G. A., Levine, J. E., Chang, A. E., Braun, T., & Mulé, J. J. (2001) · PubMed · Cited by 320
Active immunization against cancer with dendritic cells: The near future
Steinman, R. M., & Dhodapkar, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1503 · Cited by 299
Kikuchi, T., Akasaki, Y., Irie, M., Homma, S., Abe, T., & Ohno, T. (2001) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620100205 · Cited by 270
Burch, P. A., Breen, J. K., Buckner, J. C., Gastineau, D. A., Kaur, J. A., Laus, R., Padley, D. J., Peshwa, M. V., Pitot, H. C., Richardson, R. L., et al. (2000) · PubMed · Cited by 260
Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy
Fong, L., Brockstedt, D., Benike, C., Breen, J. K., Strang, G., Ruegg, C. L., & Engleman, E. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7150 · Cited by 252
HOLTL, L., RIESER, C., PAPESH, C., RAMONER, R., HEROLD, M., KLOCKER, H., RADMAYR, C., STENZL, A., BARTSCH, G., & THURNHER, M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61767-1 · Cited by 244
A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.
Chang, A. E., Redman, B. G., Whitfield, J. R., Nickoloff, B. J., Braun, T. M., Lee, P. P., Geiger, J. D., & Mulé, J. J. (2002) · PubMed · Cited by 222
Nair, S. K., Morse, M., Boczkowski, D., Ian Cumming, R., Vasovic, L., Gilboa, E., & Kim Lyerly, H. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00013 · Cited by 205
Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V., & Bohlen, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01958.x · Cited by 205
Schuler-Thurner, B., Dieckmann, D., Keikavoussi, P., Bender, A., Maczek, C., Jonuleit, H., Röder, C., Haendle, I., Leisgang, W., Dunbar, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3492 · Cited by 200
The AKT kinase is activated in multiple myeloma tumor cells
Hsu, J.-H., Shi, Y., Krajewski, S., Renner, S., Fisher, M., Reed, J. C., Franke, T. F., & Lichtenstein, A. (2001) · Blood · doi:10.1182/blood.v98.9.2853 · Cited by 196
Sadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Yamaguchi, H., Ohta, M., Fujie, T., Tanaka, F., Inoue, H., Takesako, K., et al. (2001) · PubMed · Cited by 193
Panelli, M. C., Wunderlich, J., Jeffries, J., Wang, E., Mixon, A., Rosenberg, S. A., & Marincola, F. M. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200007000-00013 · Cited by 180
Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma
Lim, S. H., & Bailey-Wood, R. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2<215::aid-ijc12>3.0.co;2-q · Cited by 163
Märten, A., Renoth, S., Heinicke, T., Albers, P., Pauli, A., Mey, U., Caspari, R., Flieger, D., Hanfland, P., von Ruecker, A., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403321467243 · Cited by 149
Wen, Y. J., Ling, M., Bailey-Wood, R., et al. (1998) · PubMed · Cited by 130
Cho, J. Y., Fox, D. A., Hořejšı́, V., Sagawa, K., Skubitz, K. M., Katz, D. R., & Chain, B. (2001) · Blood · doi:10.1182/blood.v98.2.374 · Cited by 127
Gajewski, T. F., Fallarino, F., Ashikari, A., & Sherman, M. E. (2001) · PubMed · Cited by 113
Immunotherapy for Medullary Thyroid Carcinoma by Dendritic Cell Vaccination
Schott, M., Seißler, J., Lettmann, M., Fouxon, V., Scherbaum, W. A., & Feldkamp, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7949 · Cited by 112
Nishiyama, T., Tachibana, M., Horiguchi, Y., Nakamura, K., Ikeda, Y., Takesako, K., & Murai, M. (2001) · PubMed · Cited by 110
Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells
Geiger, J. D., Hutchinson, R. J., Hohenkirk, L., McKenna, E., Chang, A. E., & Mulé, J. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02762-8 · Cited by 103
Optimizing dendritic cell‐based immunotherapy in multiple myeloma
Yi, Q., Desikan, R. K., Barlogie, B., & Munshi, N. C. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03411.x · Cited by 102
Dendritic cell vaccination for cancer therapy
Nestle, F. O. (2000) · Oncogene · doi:10.1038/sj.onc.1204095 · Cited by 82
Itoh, T., Ueda, Y., Kawashima, I., Nukaya, I., Fujiwara, H., Fuji, N., Yamashita, T., Yoshimura, T., Okugawa, K., Iwasaki, T., et al. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-001-0257-z · Cited by 80
Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer.
Rains, N., Cannan, R. J., Chen, W., & Stubbs, R. S. (2001) · PubMed · Cited by 79
Chakraborty, N. G., Sporn, J., Tortora, A. F., Kurtzman, S. H., Yamase, H., Ergin, M. T., & Mukherji, B. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050504 · Cited by 66
Toungouz, M., Libin, M., Bulté, F., Faid, L., Lehmann, F. F., Duriau, D., Laporte, M., Gangji, D., Bruyns, C., Lambermont, M., et al. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.937 · Cited by 57
Schott, M., Feldkamp, J., Schattenberg, D., Krueger, T., Dotzenrath, C., Seißler, J., & Scherbaum, W. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420300 · Cited by 56
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma
Schott, M., Feldkamp, J., Lettmann, M., Simon, D., Scherbaum, W. A., & Seißler, J. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01293.x · Cited by 39
Detection of CD4 T-cell responses to a tumor vaccine by cytokine flow cytometry.
Maecker, H. T., Auffermann-Gretzinger, S., Nomura, L. E., Liso, A., Czerwinski, D. K., & Levy, R. (2001) · PubMed · Cited by 32
Characterization of Grb4, an adapter protein interacting with Bcr-Abl
Coutinho, S., Jahn, T., Lewitzky, M., Feller, S. M., Hutzler, P., Peschel, C., & Duyster, J. (2000) · Blood · doi:10.1182/blood.v96.2.618 · Cited by 28
VACCINE THERAPY FOR PROSTATE CANCER
Tjoa, B. A., Elgamal, A. A., & Murphy, G. P. (1999) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70076-8 · Cited by 21
Hsing (1996) · doi:10.1002/(sici)1097-0215(19960208)65:4 · Cited by 1
Cited by
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Cytokines in Cancer Immunotherapy
Lee, S., & Margolin, K. (2011) · Cancers · doi:10.3390/cancers3043856 · Cited by 693
Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Bröcker, E.-B., Grabbe, S., Rittgen, W., Edler, L., Sucker, A., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj138 · Cited by 467
Therapeutic cancer vaccines: From initial findings to prospects
Song, Q., Zhang, C.-D., & Wu, X.-H. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.011 · Cited by 106
Is cancer gene therapy an empty suit?
Brenner, M. K., Gottschalk, S., Leen, A. M., & Vera, J. F. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70173-6 · Cited by 52
Metadata
- Authors
- Ridgway, D.
- Venue
- Cancer Investigation
- Publisher
- Informa UK Limited
- Published
- 2003-01
- Volume
- 21
- Issue
- 6
- Pages
- 873-886
- ISSN
- 0735-7907 (ISSN-L)
- 1532-4192
- OpenAlex
- W2060790862
- Cited by
- 278
- References
- 51
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.